Trial intelligence / Profile preview

Dexmedetomidine Nasal Spray for Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Lung Resection

NCT07579806Phase 4Not yet recruiting

Sponsor
Sichuan Provincial People's Hospital
Start
Jun 2026
Primary completion
Dec 2026
Modality
Small Molecules
01

Overview

A Phase 4 trial of dexmedetomidine in postoperative delirium (POD), sponsored by Sichuan Provincial People's Hospital. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT07579806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07579806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call